Spotlight

Mission
Impact Journals will be hosting both video and written interviews designed to highlight some of the world’s leading researchers and their institutions. This content will bring forth interesting aspects of biomedical research, and will provide useful advice for young postdocs seeking to make advances in their fields.

Longevity & Aging Series (EP 5): Dr. Amit Sharma

Aging

October 12, 2022
Dr. Amit Sharma from the SENS Research Foundation details a research paper he co-authored that was published by Aging (Aging-US), entitled, “Enhanced co-culture and enrichment of human natural killer cells for the selective clearance of senescent cells.” continue reading »

Behind the Study: Reaching Beyond Family History as Inclusion Criteria for Pancreatic Cancer Surveillance in High-risk Populations

Genes & Cancer

October 6, 2022
Dr. Louise Wang from Yale School of Medicine and the VA Connecticut Healthcare system, describes a recent editorial she co-authored that was published by Genes & Cancer, entitled, “Reaching beyond family history as inclusion criteria for pancreatic cancer surveillance in high-risk populations.” continue reading »

Behind the Study: Leveraging Scientific Findings to Develop Therapeutic Strategies for Dormant Breast Cancer Cells

Oncoscience

October 4, 2022
Alejandra Ferrer from the Department of Medicine-Hematology/Oncology at Rutgers New Jersey Medical School, describes a recent research perspective she co-authored that was published by Oncoscience, entitled, “Leveraging the scientific findings to develop therapeutic strategies for dormant breast cancer cells.” continue reading »

Behind the Study: Epigenetic Clocks Association with Perceived Discrimination, Depressive Symptoms

Aging

September 20, 2022
Dr. May Beydoun discusses a research paper she co-authored that was published by Aging (Aging-US) as the cover for Volume 14, Issue 13, entitled, “Epigenetic clocks and their association with trajectories in perceived discrimination and depressive symptoms among US middle-aged and older adults.” continue reading »

Behind the Study: Inhibition of Resistant Triple-negative Breast Cancer Cells

Oncotarget

September 19, 2022
Dr. Balraj Singh from the University of Texas MD Anderson Cancer Center, describes a recent research paper he co-authored that was published by Oncotarget, entitled, “Inhibition of resistant triple-negative breast cancer cells with low-dose 6-mercaptopurine and 5-azacitidine.” continue reading »